comparemela.com

Page 2 - Pilot Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UNC National Cancer Hub | Researchers at Lineberger react to being hub for cancer screening

The future of cancer detection, screening will come through North Carolina via UNC Lineberger which has been named a national research hub for NIH

Glycologix Treats First Patient in Pilot Study of GLX-100 for Treatment of Interstitial Cystitis/Bladder Pain Syndrome

BEVERLY, Mass. & MELBOURNE, Australia, October 24, 2023 Glycologix, Inc. ("Glycologix"), a clinical-stage company focused on developing biopolymers for the protection and repair of soft tissues, today announced the treatment of the first patient in a pilot clinical study evaluating GLX-100 as a novel treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). The multi-center pilot trial is designed to assess the safety, tolerability and effectiveness of GLX-100 in participants with IC/

Cobalt Blue Holdings Limited (ASX:COB) DFS Update

Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.